ZA839200B - Pharmaceutical compositions comprising a hydrogenated ergotalkaloid and heparin - Google Patents

Pharmaceutical compositions comprising a hydrogenated ergotalkaloid and heparin

Info

Publication number
ZA839200B
ZA839200B ZA839200A ZA839200A ZA839200B ZA 839200 B ZA839200 B ZA 839200B ZA 839200 A ZA839200 A ZA 839200A ZA 839200 A ZA839200 A ZA 839200A ZA 839200 B ZA839200 B ZA 839200B
Authority
ZA
South Africa
Prior art keywords
ergotalkaloid
heparin
hydrogenated
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
ZA839200A
Other languages
English (en)
Inventor
Hans Buehlmann
Dieter Welzel
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA839200B publication Critical patent/ZA839200B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA839200A 1982-12-10 1983-12-09 Pharmaceutical compositions comprising a hydrogenated ergotalkaloid and heparin ZA839200B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3245695 1982-12-10

Publications (1)

Publication Number Publication Date
ZA839200B true ZA839200B (en) 1985-07-31

Family

ID=6180290

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA839200A ZA839200B (en) 1982-12-10 1983-12-09 Pharmaceutical compositions comprising a hydrogenated ergotalkaloid and heparin

Country Status (25)

Country Link
JP (1) JPH0672101B2 (da)
AT (1) AT382514B (da)
AU (1) AU570658B2 (da)
BE (1) BE898356A (da)
CA (1) CA1224416A (da)
CH (1) CH656533A5 (da)
CY (1) CY1509A (da)
DD (1) DD215469B3 (da)
DK (1) DK162475C (da)
FR (1) FR2537435B1 (da)
GB (1) GB2131691B (da)
GR (1) GR79745B (da)
HK (1) HK23290A (da)
HU (1) HU190513B (da)
IE (1) IE56366B1 (da)
IL (1) IL70406A (da)
IT (1) IT1172368B (da)
LU (1) LU85127A1 (da)
NL (1) NL8304221A (da)
NZ (1) NZ206523A (da)
PH (1) PH23451A (da)
PT (1) PT77803B (da)
SE (1) SE468973B (da)
SG (1) SG53989G (da)
ZA (1) ZA839200B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432661A1 (de) * 1984-09-05 1986-03-06 Albert Prof. Dr. 6907 Nußloch Landsberger Carcinom-therapeutikum
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
IT1245761B (it) * 1991-01-30 1994-10-14 Alfa Wassermann Spa Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE441142B (sv) * 1975-12-04 1985-09-16 Sandoz Ag Forfarande for framstellning av ett terapeutiskt preparat med antitrombotiska egenskaper
DE2554533C3 (de) * 1975-12-04 1984-08-30 Sandoz-Patent-Gmbh, 7850 Loerrach Verwendung von Dihydroergotamin und Heparin
DE2809618A1 (de) * 1978-03-06 1979-09-20 Sandoz Ag Neues therapeutisches praeparat und verfahren zu dessen herstellung
DE3020895A1 (de) * 1979-06-12 1980-12-18 Sandoz Ag Ergopeptinderivate, verfahren zu deren herstellung sowie diese ergopeptinderivate enthaltende pharmazeutischen zusammensetzungen
DE2945636A1 (de) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach Stabile loesungen von hydrierten ergotalkaloiden bzw. ihren salzen und heparin bzw. seinen salzen sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
SE8306792D0 (sv) 1983-12-08
JPS59116222A (ja) 1984-07-05
IE56366B1 (en) 1991-07-03
HUT34124A (en) 1985-02-28
DD215469B3 (de) 1988-03-09
IL70406A (en) 1988-08-31
IT8349456A0 (it) 1983-12-07
DK162475C (da) 1992-05-11
PT77803A (en) 1984-01-01
CH656533A5 (de) 1986-07-15
CY1509A (en) 1990-08-03
JPH0672101B2 (ja) 1994-09-14
FR2537435B1 (fr) 1987-03-20
PH23451A (en) 1989-08-07
DK565783D0 (da) 1983-12-08
IT1172368B (it) 1987-06-18
HK23290A (en) 1990-04-06
PT77803B (en) 1986-04-17
SG53989G (en) 1989-12-29
AU2222183A (en) 1984-06-14
SE468973B (sv) 1993-04-26
AT382514B (de) 1987-03-10
DD215469A5 (de) 1984-11-14
GB2131691B (en) 1986-12-03
GB2131691A (en) 1984-06-27
BE898356A (fr) 1984-06-04
HU190513B (en) 1986-09-29
NL8304221A (nl) 1984-07-02
GR79745B (da) 1984-10-31
IE832896L (en) 1984-06-10
DK565783A (da) 1984-06-11
LU85127A1 (fr) 1984-10-22
AU570658B2 (en) 1988-03-24
GB8332653D0 (en) 1984-01-11
SE8306792L (sv) 1984-06-11
FR2537435A1 (fr) 1984-06-15
DK162475B (da) 1991-11-04
ATA428483A (de) 1986-08-15
IL70406A0 (en) 1984-03-30
CA1224416A (en) 1987-07-21
NZ206523A (en) 1987-04-30

Similar Documents

Publication Publication Date Title
NZ207885A (en) Phenethanolamine derivatives and pharmaceutical compositions
NZ211145A (en) 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
GB8326565D0 (en) Pharmaceutical compositions
GB8327612D0 (en) Pharmaceutical compositions
ZA833781B (en) Pharmaceutical compositions
PH17562A (en) 2-guanidino-4-heteroarylthiazoles and pharmaceutical compositions
NZ209095A (en) Piperidinoquinazolines and pharmaceutical compositions
GB2118176B (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
NZ198862A (en) Enkephalin derivatives and pharmaceutical compositions
ZA836703B (en) Pharmaceutical compositions
NZ208244A (en) Phenyl-pyrazol-3-ones and pharmaceutical compositions
GB8429749D0 (en) Pharmaceutical compositions
GB8313814D0 (en) Pharmaceutical compositions
DE3377696D1 (en) Pharmaceutical compositions
IL70379A (en) Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them
GB8323624D0 (en) Medicinal compositions
GB8525673D0 (en) Pharmaceutical agent
NZ205732A (en) Thiatriazine derivatives and pharmaceutical compositions
US4594359B1 (en) Pharmaceutical compositions
GB2114001B (en) Nasel pharmaceutical compositions
ZA839200B (en) Pharmaceutical compositions comprising a hydrogenated ergotalkaloid and heparin
NZ203649A (en) 2-beta-d-ribofuranosylselenazole-4-carboxamide derivatives and pharmaceutical compositions
IL68668A0 (en) Piperidinoquinazolines and pharmaceutical compositions containing them
GB8509165D0 (en) Pharmaceutical agent